高级搜索

肿瘤局部因素和放疗剂量对临床T1-4N0M0期食管鳞癌患者预后的影响

Influence of Local Tumor Factors and Radiotherapy Dose on Prognosis of Clinical Stage T1-4N0M0 Esophageal Squamous Cell Carcinoma

  • 摘要:
    目的 探讨不同放疗剂量对接受根治性放(化)疗的cT1-4N0M0期食管鳞癌患者不同肿瘤局部因素亚组人群预后的影响。
    方法 对256例临床无转移食管鳞癌患者进行回顾性分析,明确肿瘤局部因素指标预测患者预后的最佳截断值,分析近期疗效与肿瘤局部因素相关指标的关系,多因素分析影响患者OS的独立性指标,最后进行亚组分析,确定从不同放疗剂量中获益的亚组人群。
    结果 食管肿瘤病变X线长度越短、食管管壁厚度和GTV越小,患者近期疗效越好(χ2=9.066、10.310、15.661,P=0.011、0.006、<0.001)。多因素分析结果显示,食管GTV(P<0.001)、放疗剂量(P=0.038)和近期疗效(P<0.001)等3项指标为影响患者OS的独立性指标,后两项指标亦为影响患者PFS预后的独立性指标(P=0.033、P<0.001)。亚组分析结果显示放疗剂量较大(≥60 Gy)时,可使管壁最大厚度≤3.7 cm组、食管病变GTV≤37.34 cm3组和未接收同步化疗组患者OS(χ2=5.040、4.588、5.400,P=0.025、0.032、0.020)和PFS(χ2=6.089、4.353、6.459,P=0.014、0.037、0.011)均获益。
    结论 肿瘤局部因素指标为影响接受根治性放(化)疗食管鳞癌患者的重要预后因素;病变食管壁厚度和肿瘤体积较小的患者可能更能从较高的剂量(≥60 Gy)照射中获益。

     

    Abstract:
    Objective To investigate the effect of different radiotherapy doses on the prognosis of patients with stage cT1-4N0M0 esophageal squamous cell carcinoma (ESCC) who received radical radio (chemo)therapy categorized into subgroups with different tumor local factors.
    Methods A retrospective analysis was conducted on 256 patients with clinically nonmetastatic esophageal squamous cell carcinoma. The optimal cutoff for tumor local factors was determined. The relationship between latest treatment efficacy and tumor local factors was analyzed, and independent indicators affecting patient overall survival (OS) were examined using multivariate analysis. The subgroup analysis was performed to determine the correlation between selected factors and radiation therapy doses.
    Results The shorter the X-ray length of esophageal tumor lesion and the smaller the lesion canal wall thickness and gross tumor volume (GTV), the better the latest treatment efficacy of the patients (χ2=9.066, 10.310, 15.661, respectively, P=0.011, 0.006, P<0.001). Multivariate analysis results showed that GTV(P<0.001), radiation dose(P=0.038), and latest treatment efficacy(P<0.001) were independent predictors of the patients’ OS, and the latter two were also independent predictors of the patients’ progression-free survival (PFS) (P=0.033, <0.001). Subgroup analysis further showed that high doses of radiotherapy (over 60 Gy) resulted in good OS (χ2=5.040, 4.588, 5.400, P=0.025, 0.032, 0.020) and PFS (χ2=6.089, 4.353, 6.459, P=0.014, 0.037, 0.011) in the subgroup with maximum wall thickness below 3.7 cm, with esophageal lesions with GTV below 37.34 cm3, or not receiving simultaneous chemotherapy.
    Conclusion Local tumor factors are important prognostic factors of ESCC patients treated with radical radio(chemo)therapy. Patients with thin lesion walls and small tumor volumes may greatly benefit from high doses of radiation (over 60 Gy).

     

/

返回文章
返回